Rituximab: enhancing outcome of autologous stem cell transplantation in non-Hodgkin's lymphoma. [electronic resource]
- Seminars in oncology 02 2003
- 28-33 p. digital
Publication Type: Journal Article; Review
0093-7754
10.1053/sonc.2003.50022 doi
Antibodies, Monoclonal--therapeutic use Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents--therapeutic use Bone Marrow Purging Clinical Trials as Topic Hematopoietic Stem Cell Mobilization Humans Lymphoma, Mantle-Cell--drug therapy Lymphoma, Non-Hodgkin--drug therapy Rituximab Salvage Therapy Stem Cell Transplantation Transplantation, Autologous